...
首页> 外文期刊>Biotechnology Progress >Synthetic Low-Density Lipoprotein,a Novel Biomimetic Lipid Supplement for Serum-Free Tissue Culture
【24h】

Synthetic Low-Density Lipoprotein,a Novel Biomimetic Lipid Supplement for Serum-Free Tissue Culture

机译:合成的低密度脂蛋白,新型无血清组织培养仿生脂质补充剂

获取原文
获取原文并翻译 | 示例
           

摘要

Lipid supplementation in serum-free tissue culture employs solubilization techniques to permit the addition of lipids,but these systems are potentially cytotoxic and do not present lipid in a natural form.In this research a simplified preparation method for synthetic low-density lipoprotein (sLDL) has been developed that involves micro-fluidization of a solvent lipid solution in a simple aqueous solution.This produces material with size and t,potential characteristics similar to those of native LDL.sLDL supplementation in tissue culture media provides cholesterol concentrations higher than those achieved by 10% serum supplementation and existing chemically defined lipid supplements.sLDL stimulates NSO and U937 cellular proliferation in completely serum-free media,the former in a lipid concentration dependent manner that is also related to both the receptor peptide structure employed and its concentration on the particle.The greatest NSO cellular proliferation was obtained at the highest cholesterol concentration tested (0.5 mg/mL),which was 10 times higher than the cholesterol concentration achieved by standard 10% serum supplementation.U937 cellular proliferation was influenced by variation of sLDL's fatty acid constituents with a natural mixture producing maximal effect.Cell uptake studies in NSO with fluor-escently labeled sLDL indicated that assimilation is reduced by competition from native LDL.The planktonic nature of NSO cell growth meant that cell binding and uptake experiments were difficult to conduct because of cellular aggregation.However,sLDL-induced U937 proliferation is ablated by the presence of an anti-LDL receptor antibody. The results indicate that sLDL uptake is via the LDL receptor and that sLDL can function as a lipid supplement for serum-free media capable of supplementation to cholesterol concentrations up to 0.5 mg/mL.Cellular uptake studies also suggest that sLDL will be useful for the targeting and delivery of materials to cells.sLDL therefore represents a new and promising synthetic biomimetic alternative to native LDL with multiple applications.
机译:无血清组织培养中的脂质补充采用增溶技术以允许添加脂质,但这些系统具有潜在的细胞毒性,不会以天然形式存在脂质。在本研究中,合成低密度脂蛋白(sLDL)的简化制备方法已经开发出涉及在简单的水溶液中对溶剂脂质溶液进行微流化的方法,从而产生具有与天然LDL相似的大小和t,潜在特性的物质。在组织培养基中补充sLDL所提供的胆固醇浓度高于通过10%的血清补充剂和现有的化学确定的脂质补充剂。sLDL在完全无血清的培养基中刺激NSO和U937细胞增殖,前者以脂质浓度依赖性方式,还与所采用的受体肽结构及其在颗粒上的浓度有关在最高水平时获得了最大的NSO细胞增殖所测试的t胆固醇浓度(0.5 mg / mL)比标准10%血清补充的胆固醇浓度高10倍.U937细胞增殖受到sLDL脂肪酸成分变化的影响,天然混合物产生最大影响。在NSO中用荧光标记的sLDL进行的研究表明,与天然LDL的竞争减少了同化作用.NSO细胞生长的浮游性质意味着由于细胞聚集而难以进行细胞结合和摄取实验。然而,sLDL诱导的U937增殖抗-LDL受体抗体的存在消除了Aβ1α。结果表明sLDL是通过LDL受体摄取的,并且sLDL可以作为无血清培养基的脂质补充剂,能够补充高达0.5 mg / mL的胆固醇浓度。细胞摄取研究也表明sLDL将对LDL有用。因此,sLDL代表了一种新的,有前途的合成仿生替代品,可以替代具有多种应用的天然LDL。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号